Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q3 2026 · 10-Q
Revenue$65.13M$65.13M+3.6% vs Q3 2025 Net Income$3.63M$3.63MN/M vs Q3 2025 EPS Diluted$0.65$0.65N/M vs Q3 2025 Gross Profit$41,795,000+5.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$18,754,000+3.4% Free Cash Flowderived$18,022,000+4.1% Margins · derivedGross margin64.2%+0.9 pt vs Q3 2025
Operating margin12.2%+3.0 pt vs Q3 2025
Net margin5.6%+8.2 pt vs Q3 2025
ended Dec 31, 2025 · filed Feb 3, 2026 · 34 d after period end